QRP Research PT-141 (Bremelanotide) 10mg
 
PT-141, also known as Bremelanotide, is a synthetic cyclic peptide analogue derived from the alpha-melanocyte-stimulating hormone (α-MSH) pathway and has been extensively investigated in melanocortin receptor and neuroendocrine research.
PT-141 acts as a melanocortin receptor agonist, interacting with several melanocortin receptor subtypes. Research has identified particularly relevant activity involving MC1R and MC4R, alongside interactions with MC3R and MC5R.
The melanocortin system is involved in a wide range of central and peripheral biological processes. PT-141 has attracted particular scientific interest for research examining central melanocortin signalling, hypothalamic pathways, behavioural responses and neuroendocrine mechanisms.
Unlike compounds that primarily act through peripheral vascular pathways, PT-141 research has focused substantially on central nervous system melanocortin signalling, making it an important experimental compound for investigating the relationship between melanocortin receptors and neurological responses.
QRP Research PT-141 10mg is supplied as a lyophilised research peptide intended exclusively for controlled laboratory, analytical and scientific investigation.
Key Research Areas
PT-141 has been investigated experimentally in relation to:
Melanocortin receptor signalling
MC4R receptor activation
MC1R, MC3R and MC5R interactions
Central nervous system signalling
Hypothalamic pathways
Neuroendocrine mechanisms
α-MSH-related signalling
Behavioural and motivational pathways
Sexual-function-related neurobiology
Melanocortin receptor pharmacology
Peptide-receptor interactions
A particularly important characteristic of PT-141 is its activity within the central melanocortin system, especially pathways involving MC4R-expressing neurons.
This makes PT-141 a useful research compound for investigating how melanocortin receptor activation influences central neural and neuroendocrine signalling.
Research findings involving PT-141 should not be interpreted as evidence of established therapeutic, performance-enhancing or other clinical effects of this research product.
Product Specification
Compound: PT-141
Alternative Name: Bremelanotide
Compound Type: Synthetic cyclic peptide / melanocortin receptor agonist
Related Pathway: α-Melanocyte-Stimulating Hormone (α-MSH)
Research Targets: MC1R, MC3R, MC4R and MC5R
Form: Lyophilised peptide
Quantity: 10mg per vial
Brand: QRP Research
Application: Laboratory and scientific research
Why QRP Research?
QRP Research supplies specialist research materials with an emphasis on quality, consistency and traceability. Products are securely packaged and clearly identified for their intended laboratory application.
Storage
Store in a cool, dry and dark environment, protected from excessive heat, direct light and moisture.
Appropriate laboratory storage procedures should be followed to preserve the stability and integrity of the research material.
Research Use Notice
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research.
NOT for human consumption or administration.
NOT for animal consumption or administration.
NOT a medicine, food supplement or cosmetic product.
NOT intended to diagnose, treat, cure or prevent any disease.
No human dosing or administration instructions are provided.
Intended to be handled only by appropriately qualified researchers or laboratory professionals.
QRP Research PT-141 (Bremelanotide) 10mg is supplied strictly as a research material for non-clinical laboratory investigation.